Graft versus leukemia effect against juvenile myelomonocytic leukemia after unrelated cord blood transplantation

Pediatr Blood Cancer. 2008 Mar;50(3):665-7. doi: 10.1002/pbc.21200.

Abstract

A 13-month-old female underwent unrelated cord blood transplantation (CBT) for juvenile myelomonocytic leukemia (JMML). In spite of progression of the disease after a conditioning regimen with high-dose chemotherapy, a complete remission was induced in concordance with development of acute GVHD after reduction of the immunosupressant. She has been in complete remission for 1 year after transplantation. This case illustrates that CBT can provide a potent graft versus leukemia (GVL) effect against JMML.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Combined Modality Therapy
  • Cord Blood Stem Cell Transplantation*
  • Cyclosporine / therapeutic use
  • Diseases in Twins
  • Female
  • Graft vs Host Disease / etiology
  • Graft vs Leukemia Effect*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Leukemia, Myelomonocytic, Juvenile / drug therapy
  • Leukemia, Myelomonocytic, Juvenile / surgery*
  • Male
  • Remission Induction

Substances

  • Immunosuppressive Agents
  • Cyclosporine